Global Benign Prostatic Hyperplasia (BPH) Therapeutics Market Rides on Increasing Incidence of Urological Disorders
Transparency Market Research, in a report, titled "Benign Prostatic Hyperplasia (BPH) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," states that the rise in aging population, the surge in the prevalence of urological disorders, and the growing awareness about these illnesses have driven the global benign prostatic hyperplasia (BPH) therapeutics market. In contrast, the increasing adoption rate of minimally invasive surgeries threatens to hamper the expansion of the BPH market.
View full press release